WCG on Monday announced it expanded its capabilities with the introduction of Statistical Consulting Solutions. The Princeton-based firm said the offering aims to revolutionize how organizations approach statistical analysis and decision-making.
WCG’s Statistical Consulting Solutions empower biotechnology firms, contract research organizations, pharmaceutical companies, medical device manufacturers, government agencies and nonprofit organizations with comprehensive statistical support across all stages of trial design and regulatory strategy.
“Our Statistical Consulting Solutions represent a significant step forward in our commitment to empowering our clients with the tools and expertise needed to navigate the complex clinical research landscape,” Sam Srivastava, CEO of WCG, said. “By providing access to our team of seasoned statisticians, we aim to level the playing field, enabling our partners to compete more effectively in the market.”
WCG’s statisticians serve as scientific partners, collaborating closely with researchers from various disciplines to develop interventions for disease prevention and treatment. With a focus on questioning data and exploring alternative explanations, WCG’s experts bring a unique perspective to statistical analysis, ensuring robust and insightful outcomes for clients.
A partnership with WCG can provide insight from its deep expertise in clinical outcome assessment and imaging studies. Whether assisting with early-phase studies or providing support for regulatory submissions, WCG’s Statistical Consulting Solutions are tailored to meet the diverse needs of the industry.
“We recognize the critical role that statistical analysis plays in the success of clinical trials and regulatory submissions,” Srivastava said. “With our Statistical Consulting Solutions, we aim to empower our clients with the confidence and expertise needed to drive innovation and advance patient care.”
